Evidence map›Paper›PMID 18424667›Full record

ArticleBlood2008

Borrelia infection and risk of non-Hodgkin lymphoma.

Claudia Schöllkopf, Mads Melbye, Lars Munksgaard, Karin Ekström Smedby, Klaus Rostgaard, Bengt Glimelius, Ellen T Chang, Göran Roos, Mads Hansen, Hans-Olov Adami and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 97 citations in OpenAlex.

  1. Pathogenetic Mechanisms Linking Sarcoidosis to Lymphoma.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Microbiota and Hematological Diseases.International journal of hematology-oncology and stem cell research · 2022
    Review
  6. Review
  7. Article
  8. Epidemiology of Marginal Zone Lymphoma.Annals of lymphoma · 2021
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Claudia SchöllkopfDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. cko@ssi.dk
Mads Melbye
Lars Munksgaard
Karin Ekström Smedby
Klaus Rostgaard
Bengt Glimelius
Ellen T Chang
Göran Roos
Mads Hansen
Hans-Olov Adami
Henrik Hjalgrim
Statens Serum Institut · DKKarolinska Institutet · SECancer Prevention Institute of California · USCopenhagen University Hospital · DKRigshospitalet · DKUniversity Hospital of Umeå · SEUppsala University · SE

Funding

DETERMINANTS OF THE SECULAR INCREASE IN NHLR01CA069269 · NCI · STATENS SERUM INSTITUT · PI MELBYE, MADS · 1998 to 2000
$644k
NCI NIH HHS 5R07 CA69269-02
6 · The paper itself

Abstract

Reports of the presence of Borrelia burgdorferi DNA in malignant lymphomas have raised the hypothesis that infection with B. burgdorferi may be causally related to non-Hodgkin lymphoma (NHL) development. We conducted a Danish-Swedish case-control study including 3055 NHL patients and 3187 population controls. History of tick bite or Borrelia infection was ascertained through structured telephone interviews and through enzyme-linked immunosorbent assay serum analyses for antibodies against B. burgdorferi in a subset of 1579 patients and 1358 controls. Statistical associations with risk of NHL, including histologic subtypes, were assessed by logistic regression. Overall risk of NHL was not associated with self-reported history of tick bite (odds ratio [OR] = 1.0; 95% confidence interval: 0.9-1.1), Borrelia infection (OR = 1.3 [0.96-1.8]) or the presence of anti-Borrelia antibodies (OR = 1.3 [0.9-2.0]). However, in analyses of NHL subtypes, self-reported history of B. burgdorferi infection (OR = 2.5 [1.2-5.1]) and seropositivity for anti-Borrelia antibodies (OR = 3.6 [1.8-7.4]) were both associated with risk of mantle cell lymphoma. Notably, this specific association was also observed in persons who did not recall Borrelia infection yet tested positive for anti-Borrelia antibodies (OR = 4.2 [2.0-8.9]). Our observations suggest a previously unreported association between B. burgdorferi infection and risk of mantle cell lymphoma.

Indexed as

AdolescentAdultAgedAnimalsAntibodies, BacterialBites and StingsBorrelia burgdorferiCase-Control StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansIncidenceLyme DiseaseLymphoma, Mantle-CellLymphoma, Non-HodgkinMaleAntibodies, Bacterial

Identifiers

PMID18424667
PMCPMC2972577
OpenAlexW2031595462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.